Earnings Summary

Biolife Solutions, Inc.’s revenue fell -26.04% since last year same period to $32.73Mn in the Q4 2023. On a quarterly growth basis, Biolife Solutions, Inc. has generated -1.79% fall in its revenue since last 3-months.

Biolife Solutions, Inc.’s net profit jumped 72.79% since last year same period to $-13.38Mn in the Q4 2023. On a quarterly growth basis, Biolife Solutions, Inc. has generated 54.06% jump in its net profits since last 3-months.

Biolife Solutions, Inc.’s net profit margin jumped 63.21% since last year same period to -40.89% in the Q4 2023. On a quarterly growth basis, Biolife Solutions, Inc. has generated 53.22% jump in its net profit margins since last 3-months.

Biolife Solutions, Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.28 - a 17.65% jump from last quarter’s estimates.

Biolife Solutions, Inc.’s earning per share (EPS) estimates for the current year stand at -0.28.

Biolife Solutions, Inc.’s earning per share (EPS) jumped 73.91% since last year same period to -0.3 in the Q4 2023. This indicates that the Biolife Solutions, Inc. has generated 73.91% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Biolife Solutions, Inc.’s return on assets (ROA) stands at -0.08.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Biolife Solutions, Inc.’s return on equity (ROE) stands at -0.19.